EQUANIL

Equanil Adverse Events Reported to the FDA Over Time

How are Equanil adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Equanil, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Equanil is flagged as the suspect drug causing the adverse event.

Most Common Equanil Adverse Events Reported to the FDA

What are the most common Equanil adverse events reported to the FDA?

Confusional State	31 (2.83%)
Fall	30 (2.74%)
Malaise	26 (2.37%)
Somnolence	23 (2.1%)
Coma	22 (2.01%)
Eosinophilia	19 (1.74%)
Prurigo	17 (1.55%)
Eczema	16 (1.46%)
Pruritus	13 (1.19%)
Abnormal Behaviour	12 (1.1%)
Agitation	11 (1%)
	Show More
Hyponatraemia	11 (1%)
Loss Of Consciousness	11 (1%)
Pruritus Generalised	11 (1%)
Disorientation	10 (.91%)
Hypernatraemia	10 (.91%)
Miosis	10 (.91%)
Suicide Attempt	10 (.91%)
Aggression	9 (.82%)
Cardio-respiratory Arrest	9 (.82%)
Death	9 (.82%)
Vomiting	9 (.82%)
Cognitive Disorder	8 (.73%)
Leukopenia	8 (.73%)
Neutropenia	8 (.73%)
Renal Failure Acute	8 (.73%)
Sudden Death	8 (.73%)
Condition Aggravated	7 (.64%)
Dehydration	7 (.64%)
Drug Interaction	7 (.64%)
General Physical Health Deteriorati...	7 (.64%)
Grand Mal Convulsion	7 (.64%)
Hypotension	7 (.64%)
Lung Disorder	7 (.64%)
Pyrexia	7 (.64%)
Thrombocytopenia	7 (.64%)
Alanine Aminotransferase Increased	6 (.55%)
Balance Disorder	6 (.55%)
Convulsion	6 (.55%)
Eosinophil Count Increased	6 (.55%)
Face Oedema	6 (.55%)
Gamma-glutamyltransferase Increased	6 (.55%)
Head Injury	6 (.55%)
Multiple Drug Overdose Intentional	6 (.55%)
Overdose	6 (.55%)
Pulmonary Embolism	6 (.55%)
Renal Failure	6 (.55%)
Tachycardia	6 (.55%)
Urinary Retention	6 (.55%)
Altered State Of Consciousness	5 (.46%)
Aspartate Aminotransferase Increase...	5 (.46%)
Cytolytic Hepatitis	5 (.46%)
Drug Toxicity	5 (.46%)
Hypothermia	5 (.46%)
Hypothyroidism	5 (.46%)
Inflammation	5 (.46%)
Intentional Overdose	5 (.46%)
Malnutrition	5 (.46%)
Palatal Oedema	5 (.46%)
Respiratory Disorder	5 (.46%)
Rhabdomyolysis	5 (.46%)
Tremor	5 (.46%)
Urticaria	5 (.46%)
Aphasia	4 (.37%)
Blood Bilirubin Increased	4 (.37%)
Blood Creatine Phosphokinase Increa...	4 (.37%)
Bone Marrow Failure	4 (.37%)
Bradycardia	4 (.37%)
Drug Eruption	4 (.37%)
Dysphagia	4 (.37%)
Erythema	4 (.37%)
Haematoma	4 (.37%)
Hepatitis Cholestatic	4 (.37%)
Jaundice	4 (.37%)
Leukocytosis	4 (.37%)
Lip Oedema	4 (.37%)
Memory Impairment	4 (.37%)
Oedema Peripheral	4 (.37%)
Psychomotor Retardation	4 (.37%)
Respiratory Depression	4 (.37%)
Septic Shock	4 (.37%)
Wrong Drug Administered	4 (.37%)
Agranulocytosis	3 (.27%)
Alcohol Poisoning	3 (.27%)
Anorexia	3 (.27%)
Anxiety	3 (.27%)
Blood Alkaline Phosphatase Increase...	3 (.27%)
Blood Creatinine Increased	3 (.27%)
Cardiac Arrest	3 (.27%)
Cholestasis	3 (.27%)
Circulatory Collapse	3 (.27%)
Completed Suicide	3 (.27%)
Creatinine Renal Clearance Decrease...	3 (.27%)
Depressed Level Of Consciousness	3 (.27%)
Dizziness	3 (.27%)
Drug Exposure During Pregnancy	3 (.27%)
Extrapyramidal Disorder	3 (.27%)
Faecaloma	3 (.27%)
Foetal Growth Retardation	3 (.27%)
Gait Disturbance	3 (.27%)
Haematemesis	3 (.27%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Equanil, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Equanil is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Equanil

What are the most common Equanil adverse events reported to the FDA?

Neurological	95 (8.68%)
Epidermal And Dermal Conditions	88 (8.04%)
White Blood Cell	44 (4.02%)
Deliria	42 (3.84%)
Injuries	40 (3.65%)
Electrolyte And Fluid Balance Condi...	36 (3.29%)
Cardiac Arrhythmias	32 (2.92%)
Hepatic And Hepatobiliary	31 (2.83%)
Respiratory	28 (2.56%)
Hepatobiliary	26 (2.37%)
Hematology Investigations	25 (2.28%)
	Show More
Medication Errors	24 (2.19%)
Seizures	21 (1.92%)
Gastrointestinal Signs	19 (1.74%)
Mental Impairment	18 (1.64%)
Fatal Outcomes	17 (1.55%)
Infections - Pathogen Unspecified	17 (1.55%)
Chemical Injury And Poisoning	16 (1.46%)
Suicidal And Self-injurious Behavio...	16 (1.46%)
Body Temperature Conditions	15 (1.37%)
Anxiety Disorders	14 (1.28%)
Decreased And Nonspecific Blood Pre...	14 (1.28%)
Renal Disorders	14 (1.28%)
Movement Disorders	13 (1.19%)
Ocular Neuromuscular	13 (1.19%)
Psychiatric And Behavioural Symptom...	12 (1.1%)
Urinary Tract Signs	12 (1.1%)
Neuromuscular	11 (1%)
Oral Soft Tissue Conditions	11 (1%)
Therapeutic And Nontherapeutic Effe...	11 (1%)
Appetite And General Nutritional	10 (.91%)
Personality Disorders	10 (.91%)
Platelet	9 (.82%)
Anemias Nonhemolytic And Marrow Dep...	8 (.73%)
Renal And Urinary Tract Investigati...	8 (.73%)
Skin Vascular Abnormalities	8 (.73%)
Cardiac And Vascular Investigations	7 (.64%)
Enzyme	7 (.64%)
Lower Respiratory Tract Disorders	7 (.64%)
Muscle	7 (.64%)
Psychiatric	7 (.64%)
Bone And Joint Injuries	6 (.55%)
Pulmonary Vascular	6 (.55%)
Angiedema And Urticaria	5 (.46%)
Central Nervous System Vascular	5 (.46%)
Depressed Mood Disorders	5 (.46%)
Neonatal And Perinatal Conditions	5 (.46%)
Thyroid Gland	5 (.46%)
Vascular Hemorrhagic	5 (.46%)
Exocrine Pancreas Conditions	4 (.37%)
Fetal Complications	4 (.37%)
Physical Examination Topics	4 (.37%)
Vascular	4 (.37%)
Water, Electrolyte And Mineral	4 (.37%)
Bacterial Infectious	3 (.27%)
Encephalopathies	3 (.27%)
Gallbladder	3 (.27%)
Gastrointestinal Hemorrhages	3 (.27%)
Glucose Metabolism Disorders	3 (.27%)
Immunology And Allergy	3 (.27%)
Increased Intracranial Pressure And...	3 (.27%)
Lifestyle Issues	3 (.27%)
Neonatal Respiratory	3 (.27%)
Neoplasm Related Morbidities	3 (.27%)
Protein And Chemistry Analyses	3 (.27%)
Therapeutic Procedures And Supporti...	3 (.27%)
Toxicology And Therapeutic Drug Mon...	3 (.27%)
Vision	3 (.27%)
Acid-base	2 (.18%)
Communication Disorders	2 (.18%)
Cranial Nerve Disorders	2 (.18%)
Cutaneous Neoplasms Benign	2 (.18%)
Food Intolerance Syndromes	2 (.18%)
Headaches	2 (.18%)
Heart Failures	2 (.18%)
Legal Issues	2 (.18%)
Lipid Analyses	2 (.18%)
Metabolic, Nutritional And Blood Ga...	2 (.18%)
Microbiology And Serology	2 (.18%)
Mood Disorders	2 (.18%)
Musculoskeletal And Connective Tiss...	2 (.18%)
Neurological, Special Senses And Ps...	2 (.18%)
Ocular Infections, Irritations And ...	2 (.18%)
Peritoneal And Retroperitoneal Cond...	2 (.18%)
Procedural And Device Related Injur...	2 (.18%)
Protein And Amino Acid Metabolism	2 (.18%)
Red Blood Cell	2 (.18%)
Structural Brain	2 (.18%)
Arteriosclerosis, Stenosis, Vascula...	1 (.09%)
Blood And Lymphatic System Disorder...	1 (.09%)
Cardiac Disorder Signs	1 (.09%)
Changes In Physical Activity	1 (.09%)
Coagulopathies And Bleeding Diathes...	1 (.09%)
Coronary Artery	1 (.09%)
Disturbances In Thinking	1 (.09%)
Endocrine Investigations	1 (.09%)
Endocrine Neoplasms Malignant And U...	1 (.09%)
Fractures	1 (.09%)
Gastrointestinal Conditions	1 (.09%)
Gastrointestinal Motility And Defec...	1 (.09%)
Gastrointestinal Stenosis And Obstr...	1 (.09%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Equanil, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Equanil is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.